Rockwell Medical (RMTI) Non Operating Income (2018 - 2026)
Rockwell Medical (RMTI) reported Non Operating Income of -$125000.0 for Q1 2026, up 19.35% on a YoY basis from -$104729.7 in Q1 2025, and up 19.87% quarter-over-quarter from -$156000.0 in Q4 2025.
Rockwell Medical (RMTI) Non Operating Income (2018 - 2026) Analysis & Trends
Rockwell Medical has reported Non Operating Income for 9 years, with the latest figure at -$125000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 19.35% year-over-year to -$125000.0; the trailing twelve-month figure through Mar 2026 stood at -$593000.0 (up 29.07% YoY), and the FY2025 full-year result was -$623000.0, up 42.74% from the prior year.
- Non Operating Income for Q1 2026 stood at -$125000.0, up from -$156000.0 in the prior quarter.
- The five-year high for Non Operating Income was -$125000.0 in Q1 2026, with the low at -$965000.0 in Q4 2023.
- Historically, Non Operating Income has averaged -$323764.7 across 5 years, with a median of -$272000.0 in 2024.
- Annual changes were most pronounced in 2023 — Non Operating Income plunged 143.69% — and 2024, when it surged 75.44%.
- Rockwell Medical's Non Operating Income stood at -$396000.0 in 2022, then sank by 143.69% to -$965000.0 in 2023, then surged by 75.44% to -$237000.0 in 2024, then soared by 34.18% to -$156000.0 in 2025, then climbed by 19.87% to -$125000.0 in 2026.
- The last three Non Operating Income figures came in at -$125000.0 (Q1 2026), -$156000.0 (Q4 2025), and -$169000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Rockwell Medical | 26.01 Mn | 2.12 Mn | 2.90 Mn | -125,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -125,000.00 |
| Dec 31, 2025 | -156,000.00 |
| Sep 30, 2025 | -169,000.00 |
| Jun 30, 2025 | -143,000.00 |
| Mar 31, 2025 | -155,000.00 |
| Dec 31, 2024 | -237,000.00 |
| Sep 30, 2024 | -272,000.00 |
| Jun 30, 2024 | -172,000.00 |
| Mar 31, 2024 | -407,000.00 |
| Dec 31, 2023 | -965,000.00 |
| Sep 30, 2023 | -135,000.00 |
| Jun 30, 2023 | -346,000.00 |
| Mar 31, 2023 | -323,000.00 |
| Dec 31, 2022 | -396,000.00 |
| Sep 30, 2022 | -482,000.00 |
| Jun 30, 2022 | -485,000.00 |
| Mar 31, 2022 | -536,000.00 |
| Dec 31, 2021 | -582,000.00 |
| Sep 30, 2021 | -609,000.00 |
| Jun 30, 2021 | -577,000.00 |